Plasma Levels of Homocysteine is Associated with Liver Fibrosis in Health Check-Up Population

References

• Tung H-C, Hsu S-J, Tsai M-H, et al. Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats. Clin Sci. 2016;131:69–86. doi:10.1042/cs20160470
   Web of Science ®Google Scholar
• Jud P, Hafner F, Verheyen N, et al. Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease. Heart Vessels. 2018;33:1453–1462. doi:10.1007/s00380-018-1210-9
   PubMed Web of Science ®Google Scholar
• Bukharaeva E, Shakirzyanova A, Khuzakhmetova V, Sitdikova G, Giniatullin R. Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals: potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia. Front Cell Neurosci. 2015;9:391. doi:10.3389/fncel.2015.00391
   PubMed Web of Science ®Google Scholar
• Xie D, Yuan Y, Guo J, et al. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults. Sci Rep. 2015;5(1):16268. doi:10.1038/srep16268
   PubMed Web of Science ®Google Scholar
• Joseph J, Kennedy RH, Devi S, Wang J, Joseph L, Hauer-Jensen M. Protective role of mast cells in homocysteine-induced cardiac remodeling. Am J Physiol Heart Circ Physiol. 2005;288(5):H2541–H2545. doi:10.1152/ajpheart.00806.2004
   PubMed Web of Science ®Google Scholar
• Cao L, Lou X, Zou Z, et al. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats. Microvasc Res. 2013;89:146–152. doi:10.1016/j.mvr.2013.07.002
   PubMed Web of Science ®Google Scholar
• Tan H, Shi C, Jiang X, et al. Hyperhomocysteinemia promotes vascular remodeling and fibrosis in carotid vein graph in mice. Front Biosci. 2014;19:958. doi:10.2741/4260
   Web of Science ®Google Scholar
• García-Tevijano ER, Berasain C, Rodríguez JA, et al. Hyperhomocysteinemia in liver cirrhosis. Hypertension. 2001;38:1217–1221. doi:10.1161/hy1101.099499
   PubMed Web of Science ®Google Scholar
• Deffieux T, Gennisson J-L, Bousquet L, et al. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. J Hepatol. 2015;62(2):317–324. doi:10.1016/j.jhep.2014.09.020
   PubMed Web of Science ®Google Scholar
• Yoon KT, Lim SM, Park JY, et al. Liver stiffness measurement using Acoustic Radiation Force Impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci. 2012;57(6):1682–1691. doi:10.1007/s10620-012-2044-4
   PubMed Web of Science ®Google Scholar
• Sini M, Sorbello O, Civolani A, Liggi M, Demelia L. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson’s disease. Dig Liver Dis. 2012;44(6):487–491. doi:10.1016/j.dld.2011.12.010
   PubMedGoogle Scholar
• Lee J, Kim MY, Kang SH, et al. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci. 2018;75(3):128–132. doi:10.1080/09674845.2018.1459147
   PubMed Web of Science ®Google Scholar
• Boursier J, Zarski J-P, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182–1191. doi:10.1002/hep.25993
   PubMed Web of Science ®Google Scholar
• Roulot D, Roudot-Thoraval F, Nkontchou G, et al. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using fibroscan. Liver Int. 2017;37(12):1897–1906. doi:10.1111/liv.13481
   PubMed Web of Science ®Google Scholar
• Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817–1827. doi:10.1002/hep.28394
   PubMed Web of Science ®Google Scholar
• Eddowes PJ, Sasso M, Allison M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–1730. doi:10.1053/j.gastro.2019.01.042
   PubMed Web of Science ®Google Scholar
• Wang R-Q, Zhang Q-S, Zhao S-X, et al. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients. J Int Med Res. 2016;44(6):1302–1313. doi:10.1177/0300060516664638
   PubMed Web of Science ®Google Scholar
• Cengiz M, Ozenirler S. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27(11):1293–1299. doi:10.1097/meg.0000000000000445
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther. 2018;16(8):559–565. doi:10.1080/14779072.2018.1497974
   PubMed Web of Science ®Google Scholar
• Sharma M, Tiwari M, Tiwari RK. Hyperhomocysteinemia: impact on neurodegenerative diseases. Basic Clin Pharmacol Toxicol. 2015;117:287–296. doi:10.1111/bcpt.12424
   PubMed Web of Science ®Google Scholar
• Audelin MC, Genest J. Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis. 2001;159:497–511. doi:10.1016/s0021-9150(01)00531-7
   PubMed Web of Science ®Google Scholar
• Zhang J-S, Hou Y-L, Lu -W-W, et al. Intermedin(1–53) protects against myocardial fibrosis by inhibiting endoplasmic reticulum stress and inflammation induced by homocysteine in apolipoprotein E-deficient mice. J Atheroscler Thromb. 2016;23:1294–1306. doi:10.5551/jat.34082
   PubMed Web of Science ®Google Scholar
• Ding H, Gan H-Z, Fan W-J, Cao L-Y, Xu J-M, Mei Q. Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci. 2014;60:375–381. doi:10.1007/s10620-014-3379-9
   PubMed Web of Science ®Google Scholar
• Ghoul A, Moudilou E, Cherifi MEH, et al. The role of homocysteine in seminal vesicles remodeling in rat. Folia Histochem Cytobiol. 2017;55:62–73. doi:10.5603/fhc.a2017.0010
   PubMed Web of Science ®Google Scholar
• Culafic D, Markovic M, Obrenovic R, Mijac D. Plasma homocysteine levels in patients with liver cirrhosis. Vojnosanit Pregl. 2013;70(1):57–60. doi:10.2298/vsp110823032c
   PubMed Web of Science ®Google Scholar
• Bhanji RA, Ma M, Bain VG, Montano-Loza AJ. Hyperhomocysteinemia is associated with severity of cirrhosis and negative impact after liver transplantation. Liver Int. 2015;36:696–704. doi:10.1111/liv.12979
   PubMed Web of Science ®Google Scholar
• Yao L, Wang C, Zhang X, et al. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice. Hepatology. 2016;64(1):92–105. doi:10.1002/hep.28518
   PubMed Web of Science ®Google Scholar
• Zou C-G, Gao S-Y, Zhao Y-S, et al. Homocysteine enhances cell proliferation in hepatic myofibroblastic stellate cells. J Mol Med. 2009;87(1):75–84. doi:10.1007/s00109-008-0407-2
   PubMed Web of Science ®Google Scholar
• El Serafy MA, Kassem AM, Omar H, Mahfouz MS, El Said El Raziky M. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: systematic review and meta-analysis. Arab J Gastroenterol. 2017;18(2):51–57. doi:10.1016/j.ajg.2017.05.005
   PubMed Web of Science ®Google Scholar
• Papadopoulos N, Vasileiadi S, Papavdi M, et al. Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography. Ann Gastroenterol. 2019;32:498–503. doi:10.20524/aog.2019.0406
   PubMed Web of Science ®Google Scholar
• Imai H, Kamei H, Onishi Y, et al. Diagnostic usefulness of APRI and FIB-4 for the prediction of liver fibrosis after liver transplantation in patients infected with hepatitis C virus. Transplant Proc. 2018;50(5):1431–1436. doi:10.1016/j.transproceed.2018.03.005
   PubMed Web of Science ®Google Scholar
• Ding D, Li H, Liu P, et al. FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B. Int J Clin Exp Med. 2015;8:20876.
   PubMed Web of Science ®Google Scholar
• Siddiqui MS, Yamada G, Vuppalanchi R, et al. Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage. Clin Gastroenterol Hepatol. 2019;17(9):1877–1885. e1875. doi:10.1016/j.cgh.2018.12.031
   PubMed Web of Science ®Google Scholar
• Săftoiu A, Gilja OH, Sidhu PS, et al. The EFSUMB guidelines and recommendations for the clinical practice of elastography in non-hepatic applications: update 2018. Ultraschall Med. 2019;40(04):425–453. doi:10.1055/a-0838-9937
   PubMed Web of Science ®Google Scholar
• Nierhoff J, Chávez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2013;23(11):3040–3053. doi:10.1007/s00330-013-2927-6
   PubMed Web of Science ®Google Scholar
• Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013;33(8):1138–1147. doi:10.1111/liv.12240
   PubMed Web of Science ®Google Scholar
• Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Filice G, Filice C. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56(6):2125–2133. doi:10.1002/hep.25936
   PubMed Web of Science ®Google Scholar
• Cassinotto C, Lapuyade B, Mouries A, et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of supersonic shear imaging with ARFI and FibroScan®. J Hepatol. 2014;61(3):550–557. doi:10.1016/j.jhep.2014.04.044
   PubMed Web of Science ®Google Scholar
• Boursier J, Vergniol J, Guillet A, et al. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. J Hepatol. 2016;65(3):570–578. doi:10.1016/j.jhep.2016.04.023
   PubMed Web of Science ®Google Scholar
• de Lédinghen V, Wong VW-S, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan. J Hepatol. 2012;56:833–839. doi:10.1016/j.jhep.2011.10.017
   PubMed Web of Science ®Google Scholar
• Verveer C, Zondervan PE, Ten Kate FJW, Hansen BE, Janssen HLA, de Knegt RJ. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 2011;32:622–628. doi:10.1111/j.1478-3231.2011.02663.x
   PubMed Web of Science ®Google Scholar
• Zeng X, Xu C, He D, et al. Influence of hepatic inflammation on FibroScan findings in diagnosing fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol. 2015;41:1538–1544. doi:10.1016/j.ultrasmedbio.2015.01.011
   PubMed Web of Science ®Google Scholar